Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Margaret A. Hamburg thanks America's health care professionals on H1N1 vaccine safety

FDA Commissioner Margaret A. Hamburg today sent a letter to America's health care professionals thanking them for their efforts during the 2009 H1N1 influenza outbreak and providing information on safety monitoring of the 2009 H1N1 vaccines.

18 Jan 2010

Health Policy Research Roundup: New Orleans clinic experiences, health reform and lagging biomedical research funds

Journal of the American Medical Association: Funding of US Biomedical Research, 2003-2008 - After doubling in a decade, the rate of increase in biomedical research in the U.S. has slowed since 2005, and the level of funding from the National Institutes of Health and industry appears to have decreased by 2 percent in 2008, after adjusting for inflation, the authors of this study report.

18 Jan 2010

FDA extends Tarceva's sNDA review period

OSI Pharmaceuticals, Inc. and Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for Tarceva® (erlotinib) as a first-line maintenance therapy in advanced non-small cell lung cancer (NSCLC) by an additional 90 days.

18 Jan 2010

Joubert Syndrome - an inherited neurological disease found among Ashkenazi Jews

Two scientists from Cold Spring Harbor Laboratory (CSHL) are part of an international team that has discovered a genetic mutation that causes Joubert Syndrome. JBTS, as it is commonly called, is a devastating inherited neurological disease that is very rare in the general population but found relatively more often among Ashkenazi Jews.

18 Jan 2010

Safety concerns of acetaminophen

The pain reliever acetaminophen is one of the safest and most effective drugs on the market. It's often recommended instead of aspirin as a day-to-day pain reliever because it's much easier on the stomach than other over-the-counter options and is considered safe when taken properly.

18 Jan 2010

Scientists develop alternative method for producing active ingredient in Tamiflu

Scientists have developed an alternative method for producing the active ingredient in Tamiflu-, the mainstay for fighting H1N1 and other forms of influenza. The new process could expand availability of the drug by reducing its cost, which now retails for as about $8 per dose.

18 Jan 2010

U.S. DOD awards LUHS $1.6M to continue burn research

Loyola University Health Systems (LUHS) has received a $1.6 million contract from the U.S. Department of Defense (DOD) to research burn injuries, the care of burn wounds and infections and how burns affect the immune system.

18 Jan 2010

Kenta Biotech and Rentschler Biotechnologie sign agreement to develop antibody against MRSA

Kenta Biotech today announced an agreement with Rentschler Biotechnologie for the development of a fully human monoclonal antibody against methicillin-resistant Staphylococcus aureus (MRSA).

18 Jan 2010

Multiple issues still on the table in House-Senate health bill negotiations

Reports explored contentious policies in the House and Senate versions of the health-overhaul legislation that are part of the final negotiations.

18 Jan 2010

IGC scientist wins ERC grant for neuroscience research

Zachary Mainen, coordinator of the Champalimaud Foundation Neuroscience Programme at the IGC, has become one of the most recent winners of the prestigious and highly competitive European Research Council grants, to the value of 2.3 million euro, for a period of five years.

18 Jan 2010

Cerus' INTERCEPT platelets therapeutically effective even after seven days of storage

Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.

18 Jan 2010

AVIR Green Hills Biotechnology commences deltaFLU Phase II study

AVIR Green Hills Biotechnology, the innovative biotech company based in Vienna, has started the New Year by embarking on the first clinical phase II study for the seasonal vaccine deltaFLU. The study will be carried out at the Medical University of Vienna. With this step, AVIR Green Hills has set yet another important milestone in the development of effective and modern influenza vaccines.

18 Jan 2010

WHO official rejects claims agency overhyped threat of H1N1

Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports.

18 Jan 2010

Shionogi receives approval to develop and commercialize intravenous peramivir in Japan

BioCryst Pharmaceuticals, Inc. today announced that its partner, Shionogi & Co., Ltd. has received marketing and manufacturing approval for intravenous (i.v.) peramivir to treat patients with influenza in Japan.

13 Jan 2010

Whitley urges public to get vaccinated against H1N1 influenza virus

With several months left in the influenza season and growing supplies of vaccine, now is an opportune time to get vaccinated against the 2009 H1N1 influenza virus, says Richard Whitley, M.D., director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases and current president of the Infectious Diseases Society of America (IDSA).

13 Jan 2010

New genetic evidence can improve avian influenza surveillance programs

Genetic analyses of avian influenza in wild birds can help pinpoint likely carrier species and geographic hot spots where Eurasian viruses would be most likely to enter North America, according to new U.S. Geological Survey research.

13 Jan 2010

Massage Heights Houston opens new retreat in Royal Oaks area of Houston

Just in time for one of the most romantic holidays for couples -- Valentine's Day -- Massage Heights Houston opened its 11th Houston location on December 18th, 2009 in the Royal Oaks area of Houston.

13 Jan 2010

Record-breaking 8,300 health care professionals participate in online H1N1 vaccination education program

A record-breaking 8,300 front-line health care professionals participated in an accredited, online education program about H1N1 vaccination in November 2009 alone.

13 Jan 2010

Study recommends improvements for scaling up child survival programs

New child survival programs must engage evaluation teams from the start to identify the major causes of child mortality in intervention areas and to ensure that appropriate resources are available to scale up coverage and treatment, according to a retrospective evaluation led by researchers at the Johns Hopkins Bloomberg School of Public Health.

13 Jan 2010

Send Word Now to provide emergency voice and text communication services to Unity Health System's hospitals

Send Word Now, the leading provider of emergency notification and on-demand alerting and response services, announced today that Unity Health System, a 681-bed health-care network based out of Rochester, New York, has selected Send Word Now to provide emergency voice and text communication services to its hospitals.

13 Jan 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Margaret A. Hamburg thanks America's health care professionals on H1N1 vaccine safety

Health Policy Research Roundup: New Orleans clinic experiences, health reform and lagging biomedical research funds

FDA extends Tarceva's sNDA review period

Joubert Syndrome - an inherited neurological disease found among Ashkenazi Jews

Safety concerns of acetaminophen

Scientists develop alternative method for producing active ingredient in Tamiflu

U.S. DOD awards LUHS $1.6M to continue burn research

Kenta Biotech and Rentschler Biotechnologie sign agreement to develop antibody against MRSA

Multiple issues still on the table in House-Senate health bill negotiations

IGC scientist wins ERC grant for neuroscience research

Cerus' INTERCEPT platelets therapeutically effective even after seven days of storage

AVIR Green Hills Biotechnology commences deltaFLU Phase II study

WHO official rejects claims agency overhyped threat of H1N1

Shionogi receives approval to develop and commercialize intravenous peramivir in Japan

Whitley urges public to get vaccinated against H1N1 influenza virus

New genetic evidence can improve avian influenza surveillance programs

Massage Heights Houston opens new retreat in Royal Oaks area of Houston

Record-breaking 8,300 health care professionals participate in online H1N1 vaccination education program

Study recommends improvements for scaling up child survival programs

Send Word Now to provide emergency voice and text communication services to Unity Health System's hospitals

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in